Which procedure is better for atrial fibrillation, cardioversion or defibrillation?

Cardioversion is better for atrial fibrillation because it uses a lower-energy synchronized shock to restore normal rhythm, whereas defibrillation is designed for life-threatening ventricular arrhythmias and is not used for AFib.

How much does cardioversion cost compared to defibrillation?

Cardioversion typically costs between $2,000 and $10,000 depending on setting and sedation, while defibrillation is usually performed during emergency cardiac arrest care, costing $1,500 to $5,000 as part of a larger resuscitation episode.

Is cardioversion safer than defibrillation for conscious patients?

Yes, cardioversion is safer for conscious patients because it uses synchronized, lower-energy shocks with sedation, whereas defibrillation is an emergency measure for unconscious patients in cardiac arrest with no pulse.

Can a defibrillator be used for cardioversion in an emergency?

Yes, a defibrillator can be used for cardioversion by switching to synchronized mode, but only trained providers should do this because unsynchronized shocks can trigger ventricular fibrillation in stable rhythms.

What is the most common mistake beginners make when choosing between cardioversion and defibrillation?

The most common mistake is using defibrillation for stable tachycardias like atrial flutter, which requires synchronized cardioversion instead; unsynchronized shocks can worsen the rhythm and cause cardiac arrest.

Are cardioversion and defibrillation interchangeable for treating ventricular tachycardia?

No, they are not interchangeable for ventricular tachycardia: stable VT with a pulse requires synchronized cardioversion, while pulseless VT or VF requires immediate unsynchronized defibrillation to restore a perfusing rhythm.

Can I switch from scheduled cardioversion to emergency defibrillation if my condition worsens?

Yes, you can switch from scheduled cardioversion to emergency defibrillation if your rhythm deteriorates into pulseless ventricular tachycardia or fibrillation, because the clinical priority shifts from rhythm restoration to immediate life support.

What real-world scenario uses cardioversion instead of defibrillation?

A real-world scenario for cardioversion is a patient with symptomatic atrial fibrillation and a heart rate of 150 who is stable, where a synchronized shock restores sinus rhythm; defibrillation is reserved for collapse with no pulse.

Which procedure has a higher success rate, cardioversion or defibrillation?

Defibrillation has a higher immediate success rate for terminating ventricular fibrillation (up to 90% with early shocks), while cardioversion success for atrial fibrillation ranges from 50% to 90% depending on duration and underlying heart disease.

Difference Between

Difference Between Cardioversion and Defibrillation

Written byNex Virox Team

Editorial Team

Reviewed byVarshal Nirbhavane

Senior SEO & Organic Growth Professional · 5+ years

Published: September 7, 202622 min read

Quick answer

The main difference between Cardioversion and Defibrillation is that cardioversion uses synchronized, timed shocks to restore a normal rhythm in stable arrhythmias, while defibrillation delivers unsynchronized high-energy shocks to stop life-threatening chaotic rhythms. Cardioversion is a planned procedure for atrial fibrillation or flutter, while Defibrillation is an emergency treatment for ventricular fibrillation or pulseless ventricular tachycardia.

Key takeaways

Core distinction: Cardioversion delivers a synchronized shock timed to the heartbeat, while defibrillation uses an unsynchronized shock for chaotic rhythms.
How each works: Cardioversion resets atrial or ventricular rhythms like AFib, whereas defibrillation depolarizes the entire heart muscle to stop ventricular fibrillation.
Urgency and settings: Defibrillation is an emergency, life-saving procedure for cardiac arrest, while cardioversion is often elective and performed in a controlled hospital setting.
Best-fit use case: Use cardioversion for stable but abnormal rhythms; use defibrillation immediately for pulseless ventricular tachycardia or ventricular fibrillation.
Most common mistake: Applying a defibrillator shock to a stable rhythm can trigger cardiac arrest, so always confirm the rhythm before choosing synchronized cardioversion.

Table of Contents18 sections

Difference Between Cardioversion and Defibrillation: Comparison Table

Aspect	Cardioversion	Defibrillation
Definition	A synchronized electrical shock delivered to terminate organized arrhythmias like atrial fibrillation.	An unsynchronized high-energy shock used to terminate chaotic rhythms such as ventricular fibrillation.
Primary Purpose	Restores normal sinus rhythm in stable patients with supraventricular tachycardias or atrial flutter.	Emergently restores perfusing rhythm in cardiac arrest from pulseless ventricular tachycardia or fibrillation.
Core Mechanism	Shock is timed to the R wave on ECG, avoiding the vulnerable T-wave period.	Shock is delivered immediately without timing, depolarizing the entire myocardium simultaneously.
Energy Setting	Typically uses lower energy, ranging from 50 to 200 joules depending on rhythm and device.	Typically uses higher energy, ranging from 120 to 360 joules in biphasic defibrillators.
Shock Synchronization	Requires synchronization feature enabled on the defibrillator to match cardiac cycle.	Deliberately unsynchronized; synchronization is disabled to avoid delay in shock delivery.
Clinical Urgency	Performed as a scheduled or semi-urgent procedure in hemodynamically stable patients.	Performed as an immediate, life-saving intervention during pulseless cardiac arrest.
Patient Consciousness	Usually requires sedation or general anesthesia because the patient is awake and aware.	Patient is unconscious due to cardiac arrest; no sedation is required before shock delivery.
ECG Rhythm Target	Targets atrial fibrillation, atrial flutter, and stable ventricular tachycardia with a pulse.	Targets ventricular fibrillation and pulseless ventricular tachycardia only.
Shock Timing Precision	Shock delivery is delayed milliseconds to align with the QRS complex on the monitor.	Shock is delivered instantly upon confirmation of a shockable rhythm, with zero delay.
Risk of T-Wave Shock	Synchronization prevents shock during T wave, reducing risk of inducing ventricular fibrillation.	No synchronization, but the patient is already in a fatal arrhythmia, so risk is irrelevant.
Typical Joule Range	Biphasic devices often use 70 to 120 joules for atrial fibrillation cardioversion.	Biphasic defibrillation typically uses 120 to 200 joules for adult cardiac arrest.
Procedure Setting	Performed in electrophysiology labs, cardiac catheterization labs, or intensive care units.	Performed anywhere cardiac arrest occurs, including wards, emergency rooms, and public spaces.
Staff Skill Level	Requires advanced training in ECG interpretation and airway management with sedation protocols.	Requires Basic Life Support skills; automated external defibrillators enable layperson use.
Success Rate	Immediate success for atrial fibrillation is approximately 90% with biphasic shocks.	Survival to discharge after out-of-hospital arrest remains below 10% in most regions.
Time to Shock	Procedure is elective; timing is planned, often after anticoagulation and fasting protocols.	Shock is delivered within minutes of arrest; every minute of delay reduces survival by 7-10%.
Post-Shock Care	Patient requires monitoring for arrhythmia recurrence, sedation recovery, and anticoagulation management.	Patient requires immediate CPR continuation, post-resuscitation care, and targeted temperature management.
Device Type Used	Monophasic or biphasic defibrillator with synchronized mode and ECG display capability.	Manual defibrillator, automated external defibrillator, or wearable cardioverter-defibrillator.
Indication for Use	Indicated for symptomatic but stable tachyarrhythmias refractory to medication.	Indicated exclusively for cardiac arrest with shockable rhythm on rhythm analysis.
Contraindications	Avoid in digitalis toxicity, severe hypokalemia, or patients with atrial thrombi without anticoagulation.	No absolute contraindications; the alternative is certain death without defibrillation.
Complication Rate	Rare complications include thromboembolism, pulmonary edema, and skin burns at pad sites.	Complications include rib fractures from CPR, aspiration, and post-shock myocardial stunning.
Anticoagulation Need	Requires 3-4 weeks of therapeutic anticoagulation before elective cardioversion for atrial fibrillation.	No anticoagulation is given during arrest; antiplatelet or anticoagulant therapy is considered post-arrest.
Pad Placement	Anterolateral or anteroposterior pad positions are both acceptable for synchronized shocks.	Anterolateral placement is standard; anteroposterior is used when anterior pads are contraindicated.
Shock Waveform	Biphasic truncated exponential waveform is preferred for lower energy requirements.	Biphasic waveforms are standard; monophasic is now rarely used in modern devices.
Recovery Time	Patients typically recover from sedation within 1-2 hours and may discharge same day.	Survivors require intensive care for days to weeks, with significant neurological recovery variability.
Training Requirement	Requires physician-level training, typically cardiologists or intensivists with advanced cardiac life support.	Basic Life Support training suffices for AED use; Advanced Cardiac Life Support for manual defibrillation.
Cost of Procedure	Elective cardioversion costs vary from $2,000 to $10,000 including facility and professional fees.	In-hospital defibrillation adds minimal cost; total arrest care often exceeds $50,000 for survivors.
Common Misconception	Often confused with defibrillation, but cardioversion never treats ventricular fibrillation.	Often mistakenly used for asystole or pulseless electrical activity, where defibrillation has no benefit.
Best-Fit Scenario	Best for stable atrial fibrillation with rapid ventricular rate causing symptoms like palpitations or dyspnea.	Best for witnessed collapse with shockable rhythm; immediate defibrillation within 3-5 minutes maximizes survival.

What Is Cardioversion?

Cardioversion is a medical procedure that restores a normal heart rhythm using synchronized electrical shocks or medications. It treats arrhythmias like atrial fibrillation and atrial flutter. The procedure aims to improve blood flow and reduce symptoms such as palpitations, fatigue, and shortness of breath.

Definition of Cardioversion

Cardioversion is the deliberate delivery of a synchronized direct-current electrical shock to the heart, timed to the QRS complex, or the administration of antiarrhythmic drugs, to terminate a tachyarrhythmia and re-establish sinus rhythm. It is distinguished from defibrillation by its synchronization and its use for organized rhythms.

Key Characteristics of Cardioversion

Characteristic	What It Means in Practice
Synchronized shock	The electrical impulse is timed to the R wave, avoiding the vulnerable T wave period and reducing ventricular fibrillation risk.
Sedation requirement	Patients receive short-acting anesthesia or conscious sedation before the shock, ensuring comfort and amnesia during the brief procedure.
Rhythm targeting	It treats organized arrhythmias like atrial fibrillation, atrial flutter, and re-entrant supraventricular tachycardias, not chaotic rhythms.
Energy settings	Typical biphasic shocks range from 100 to 200 joules for atrial fibrillation, with lower energies used for atrial flutter.
Timing precision	The shock is delivered milliseconds after the R wave, requiring real-time ECG monitoring to ensure correct synchronization.
Stroke prevention	Anticoagulation therapy is often required before and after the procedure to prevent clot dislodgement and embolic stroke.
Success rate	Immediate success in restoring sinus rhythm occurs in approximately 90% of elective procedures, though long-term maintenance varies.
Non-invasive option	It can be performed externally through chest pads or internally via electrode catheters, depending on the clinical scenario.
Pharmacologic alternative	Chemical cardioversion uses drugs like amiodarone or flecainide, offering a slower rhythm conversion without electrical shock.
Recovery time	Patients typically recover within one to two hours, with vital signs monitored until they are fully awake and stable.

Common Examples of Cardioversion

Atrial fibrillation – The most common indication, converting irregular, rapid atrial activity back to coordinated sinus rhythm.
Atrial flutter – A regular, rapid atrial rhythm that responds well to lower-energy synchronized shocks, often at 50 to 100 joules.
Supraventricular tachycardia – Re-entrant tachycardias like AV nodal re-entry are terminated with synchronized cardioversion when drugs fail.
Wolff-Parkinson-White syndrome – Cardioversion terminates accessory pathway-mediated tachycardias that can be life-threatening if prolonged.
Elective outpatient procedure – Scheduled cardioversion for persistent atrial fibrillation allows pre-procedure anticoagulation and fasting preparation.
Emergency hemodynamic collapse – Urgent cardioversion is performed when tachyarrhythmia causes hypotension, chest pain, or heart failure symptoms.
Postoperative arrhythmia – New-onset atrial fibrillation after cardiac surgery is frequently managed with electrical cardioversion to stabilize the patient.
Chemical cardioversion – Intravenous antiarrhythmic drugs like ibutilide convert atrial fibrillation without the need for anesthesia.
Recurrent arrhythmia management – Repeat cardioversion sessions are used for patients with paroxysmal arrhythmias that recur despite medication.
Pediatric congenital heart disease – Synchronized cardioversion treats arrhythmias in children with structural heart defects, using age-appropriate energy doses.

Advantages and Limitations of Cardioversion

Advantages	Limitations
Restores normal rhythm quickly, often within seconds, providing immediate symptom relief for palpitations and breathlessness.	Success is not permanent; arrhythmia recurrence rates reach 50% or higher within one year without ongoing antiarrhythmic therapy.
It is a minimally invasive procedure performed under conscious sedation, avoiding the need for surgical incisions or prolonged hospital stays.	Thromboembolic stroke risk exists if the left atrial appendage contains clots, requiring transesophageal echocardiography or adequate anticoagulation beforehand.
Electrical cardioversion has a high immediate success rate, restoring sinus rhythm in about 90% of elective procedures.	Anesthesia risks include respiratory depression, hypotension, and allergic reactions, particularly in elderly or frail patients.
It avoids the long-term side effects of antiarrhythmic drugs, such as pulmonary toxicity from amiodarone or proarrhythmia from class IC agents.	Skin burns and chest discomfort can occur at the pad sites, though modern gel pads reduce this complication significantly.
The procedure can be repeated safely multiple times if arrhythmias recur, offering a flexible management strategy for chronic conditions.	It does not address the underlying cause of arrhythmia, such as hypertension, valvular disease, or sleep apnea, so recurrence is common.
Cardioversion improves cardiac output and exercise tolerance by restoring atrioventricular synchrony and regular ventricular response.	Patients with atrial fibrillation lasting over 48 hours require three to four weeks of anticoagulation, delaying the procedure significantly.
It is a cost-effective outpatient procedure, typically completed within a few hours without intensive care admission.	Immediate recurrence of arrhythmia occurs in up to 10% of cases, requiring repeat shocks or additional drug therapy.
Chemical cardioversion avoids anesthesia and electrical risks, making it suitable for patients with contraindications to sedation.	Pharmacologic conversion has a lower success rate of 50-70% and carries risks of QT prolongation, torsades de pointes, and bradycardia.
It provides rapid hemodynamic stabilization in unstable patients, preventing progression to ventricular fibrillation or cardiogenic shock.	Post-cardioversion atrial stunning can cause transient left atrial dysfunction, increasing stroke risk even after successful rhythm conversion.
Elective cardioversion improves quality of life by eliminating arrhythmia-related anxiety, fatigue, and exercise intolerance.	It is ineffective for ventricular fibrillation or pulseless ventricular tachycardia, which require unsynchronized defibrillation as the emergency treatment.

What Is Defibrillation?

Defibrillation is an emergency medical procedure that delivers a high-energy electric shock to the heart to stop chaotic arrhythmias like ventricular fibrillation. It exists to restore a normal heartbeat when the heart's electrical system fails, and it is the only effective treatment for cardiac arrest caused by these rhythms.

Definition of Defibrillation

Defibrillation is the therapeutic application of a controlled, direct-current electrical impulse across the myocardium to depolarize the entire heart muscle simultaneously, terminating lethal arrhythmias. This synchronized interruption of chaotic electrical activity allows the sinoatrial node to resume its role as the primary pacemaker and re-establish organized cardiac output.

Key Characteristics of Defibrillation

Characteristic	What It Means in Practice
Unsynchronized delivery	The shock is delivered randomly within the cardiac cycle, unlike cardioversion which is timed to the QRS complex.
High energy levels	Typical biphasic defibrillation uses 120-200 joules, while monophasic devices may deliver 360 joules for adult patients.
Emergency-only use	It is reserved for pulseless ventricular tachycardia and ventricular fibrillation, not for stable arrhythmias.
Time-critical intervention	Survival decreases by 7-10% for every minute of delay, making immediate access to an AED essential.
Full cardiac depolarization	The shock simultaneously depolarizes all myocardial cells, creating a brief period of electrical silence.
No sedation required	Patients are unconscious during cardiac arrest, eliminating the need for anesthetic agents before shock delivery.
Biphasic waveform standard	Modern devices use biphasic waveforms that achieve success with lower energy and cause less myocardial damage.
Pad or paddle placement	Electrodes are placed in anterolateral or anteroposterior positions to maximize current flow through the heart.
Repeatable procedure	Multiple shocks can be delivered with escalating energy, alternating with CPR and vasopressor administration.
Automated availability	Automated external defibrillators analyze heart rhythms and only advise shock delivery for shockable rhythms.

Common Examples of Defibrillation

Ventricular fibrillation - This chaotic rhythm causes quivering ventricles with no effective pumping, requiring immediate defibrillation to restore circulation.
Pulseless ventricular tachycardia - This rapid, organized rhythm produces no cardiac output, and defibrillation is the definitive treatment when pulses are absent.
Automated external defibrillator use - Public-access AEDs guide lay rescuers through voice prompts to deliver shocks safely in community settings.
Implantable cardioverter-defibrillator firing - These internal devices automatically detect lethal arrhythmias and deliver shocks within seconds without human intervention.
In-hospital code blue response - Emergency teams use manual defibrillators with synchronized monitoring during resuscitation efforts on hospital wards.
Sports arena emergency action plan - Athletic venues maintain AEDs on-site because sudden cardiac arrest is a leading cause of death in young athletes.
Airport terminal deployment - Major transportation hubs position AEDs every 1-2 minutes of walking distance to improve survival from witnessed collapse.
Wearable defibrillator vest - Patients at temporary risk wear these devices that automatically shock if a lethal rhythm develops while awaiting ICD placement.
Emergency medical services response - Paramedics carry manual defibrillators on ambulances and deliver shocks en route to hospital for refractory arrest cases.
Post-operative cardiac monitoring - Defibrillation is available immediately after open-heart surgery when arrhythmias commonly occur during recovery.

Advantages and Limitations of Defibrillation

Advantages	Limitations
Defibrillation is the only proven treatment that can convert ventricular fibrillation to a perfusing rhythm, offering genuine hope of survival.	Defibrillation is completely ineffective for non-shockable rhythms like asystole or pulseless electrical activity, wasting precious resuscitation time.
Modern biphasic defibrillators achieve first-shock success rates exceeding 90% for short-duration ventricular fibrillation when applied promptly.	Each minute of delayed defibrillation reduces survival probability by 7-10%, meaning outcomes are poor when response times exceed 5 minutes.
Automated external defibrillators enable untrained bystanders to deliver life-saving shocks safely, dramatically expanding access to treatment in public spaces.	Defibrillation does not address the underlying cause of cardiac arrest, such as coronary occlusion or electrolyte imbalance, so recurrence is common.
Implantable cardioverter-defibrillators provide continuous protection and can terminate lethal arrhythmias within seconds, preventing sudden cardiac death.	Repeated defibrillation shocks can cause myocardial injury, including ST-segment elevation, enzyme release, and transient contractile dysfunction.
Defibrillation is a rapid intervention that takes only seconds to perform, allowing immediate resumption of chest compressions to maintain organ perfusion.	Defibrillation without effective CPR between shocks fails to generate adequate cerebral blood flow, leading to poor neurological outcomes even after successful conversion.
Biphasic waveforms use lower energy levels than monophasic devices, reducing the risk of skin burns and post-shock myocardial stunning.	Defibrillation can cause iatrogenic harm, including rib fractures from pad pressure, aspiration from vomiting, and electrical injury to rescuers if safety protocols are breached.
Defibrillation is a standardized, protocol-driven procedure with clear algorithms that can be taught to first responders and laypersons alike.	Defibrillation success depends heavily on shockable rhythm identification, and delivering a shock to a non-shockable rhythm provides no benefit.
Portable defibrillators are lightweight, battery-operated, and rugged, making them suitable for use in ambulances, aircraft, and remote field settings.	Defibrillation does not restore normal heart function permanently; patients require post-resuscitation care including targeted temperature management and revascularization.
Defibrillation can be repeated multiple times during a resuscitation attempt, with escalating energy levels and alternating cycles of CPR.	Defibrillation is a painful procedure when delivered to a conscious patient, which is why it is strictly limited to pulseless arrest situations.
Wearable defibrillator vests offer continuous protection for patients awaiting ICD placement, reducing the risk of sudden death during the waiting period.	Defibrillation devices require regular maintenance, battery replacement, and electrode pad renewal to ensure functional readiness, creating logistical burdens.

Similarities Between Cardioversion and Defibrillation

Shared Aspect	How Cardioversion and Defibrillation Are Alike
Energy Delivery	Both cardioversion and defibrillation deliver a controlled electric shock to the heart through electrodes placed on the patient's chest.
Primary Goal	The primary goal of both cardioversion and defibrillation is to restore a normal, effective heart rhythm from an abnormal one.
Medical Procedure	Both cardioversion and defibrillation are invasive medical procedures performed by trained healthcare professionals in emergency or controlled settings.
Electrical Current	Cardioversion and defibrillation both use a direct current (DC) electrical shock to depolarize the heart muscle cells simultaneously.
Electrode Placement	Both cardioversion and defibrillation require placement of adhesive pads or paddles on the chest in standard anterior-lateral or anterior-posterior positions.
Cardiac Arrhythmias	Both cardioversion and defibrillation treat tachyarrhythmias—conditions where the heart beats too fast—including atrial fibrillation and ventricular tachycardia.
Defibrillator Device	Both cardioversion and defibrillation are performed using a defibrillator device that generates and delivers the required electrical shock.
Rapid Action	Both cardioversion and defibrillation require prompt action to prevent hemodynamic collapse, organ damage, or cardiac arrest in unstable patients.
Consciousness Handling	Both cardioversion and defibrillation may require sedation or anesthesia; defibrillation for unconscious patients, cardioversion often for conscious ones.
Rhythm Monitoring	Both cardioversion and defibrillation rely on continuous ECG monitoring to confirm the arrhythmia and verify successful rhythm conversion afterward.
Shock Synchronization	Both cardioversion and defibrillation can be performed with synchronized shocks (for regular rhythms) or unsynchronized shocks (for chaotic rhythms like VF).
Clinical Guidelines	Both cardioversion and defibrillation follow standardized protocols from the American Heart Association (AHA) and European Resuscitation Council (ERC) guidelines.
Emergency Use	Both cardioversion and defibrillation are critical emergency interventions used in advanced cardiac life support (ACLS) algorithms for life-threatening arrhythmias.
Risk of Burns	Both cardioversion and defibrillation carry a risk of minor skin burns at electrode sites, minimized with proper gel or pad usage.
Post-Shock Care	Both cardioversion and defibrillation require immediate post-shock assessment of vital signs, oxygen saturation, and neurological status.
Training Required	Both cardioversion and defibrillation require specialized training in rhythm recognition, shock delivery, and resuscitation algorithms for safe execution.
Contraindications	Both cardioversion and defibrillation are contraindicated in patients with digitalis toxicity or severe electrolyte imbalances, as these increase arrhythmia risk.
Equipment Setup	Both cardioversion and defibrillation require the same core equipment: defibrillator, pads, ECG leads, and rescue medications like amiodarone or lidocaine.
Time Sensitivity	Both cardioversion and defibrillation have time-critical outcomes; earlier shock delivery improves success rates and reduces mortality, especially in VF.
Mechanism of Action	Both cardioversion and defibrillation work by delivering a shock that interrupts abnormal electrical circuits, allowing the heart's natural pacemaker to resume control.
Patient Preparation	Both cardioversion and defibrillation require the patient to be placed on a firm surface, with chest hair shaved if needed, and skin dried for pad adhesion.
Complication Profile	Both cardioversion and defibrillation share complications: thromboembolism, myocardial injury, arrhythmia recurrence, and transient hypotension.
Success Definition	Both cardioversion and defibrillation define success as termination of the abnormal rhythm and restoration of sinus rhythm or a stable perfusing rhythm.
Repeat Shocks	Both cardioversion and defibrillation may require multiple shocks with escalating energy levels if the first attempt fails to convert the rhythm.
Medication Adjuncts	Both cardioversion and defibrillation are often combined with antiarrhythmic drugs (e.g., amiodarone, procainamide) to enhance efficacy and prevent recurrence.
Documentation Needs	Both cardioversion and defibrillation require detailed documentation of shock energy, number of shocks, rhythm before/after, and patient response for medical records.
Cost Considerations	Both cardioversion and defibrillation involve similar costs—defibrillator equipment, disposable pads, sedation drugs, and hospital facility fees—typically covered by insurance.
Long-Term Follow-up	Both cardioversion and defibrillation necessitate long-term follow-up with cardiology, including repeat ECGs, Holter monitoring, and management of underlying heart disease.
Outcome Measurement	Both cardioversion and defibrillation measure outcomes using survival rates, rhythm stability at 24 hours, and absence of stroke or heart failure events.
Patient Education	Both cardioversion and defibrillation require patient education about the procedure, risks, lifestyle changes, and signs of arrhythmia recurrence before discharge.

Cardioversion or Defibrillation: Which Should You Choose?

The deciding variable is the patient's hemodynamic stability. Cardioversion treats unstable tachyarrhythmias with a pulse, while defibrillation is reserved for pulseless cardiac arrest. Choose the therapy based on the presence of a pulse, not the rhythm alone.

When to Use Cardioversion

Choose cardioversion when the patient has a pulse but is unstable, showing hypotension, chest pain, or heart failure. It is synchronized to the QRS complex to avoid R-on-T phenomenon. Use it for atrial fibrillation, atrial flutter, or stable ventricular tachycardia with symptoms.

When to Use Defibrillation

Choose defibrillation when the patient is pulseless in ventricular fibrillation or pulseless ventricular tachycardia. It is unsynchronized and delivers a high-energy shock to terminate chaotic rhythm. Start at 120-200 J biphasic, then escalate. Perform CPR before and after each shock.

Common Misconceptions About Cardioversion and Defibrillation

Common Myth	The Reality
"Cardioversion and defibrillation are the exact same procedure."	Cardioversion uses a synchronized shock timed to the QRS complex, while defibrillation delivers an unsynchronized shock; the timing difference is critical for safety and efficacy.
"Defibrillation is only used when the heart has stopped beating."	Defibrillation treats chaotic rhythms like ventricular fibrillation or pulseless ventricular tachycardia, where the heart quivers without pumping, not a fully stopped heart (asystole).
"Cardioversion is always a scheduled, elective procedure."	Cardioversion can be elective for stable atrial fibrillation, but it is also performed emergently for unstable tachyarrhythmias like atrial flutter with hypotension.
"A higher joule setting always works better for both procedures."	Cardioversion typically uses lower energy (50–200 J biphasic) for atrial arrhythmias, while defibrillation uses higher energy (120–360 J); excessive joules can damage myocardial tissue.
"Both procedures require the patient to be awake and alert."	Cardioversion usually requires short-acting sedation or anesthesia for comfort, while defibrillation in cardiac arrest is performed on an unconscious patient with no sedation needed.
"Synchronization is a safety feature used in defibrillation."	Synchronization is used exclusively in cardioversion to avoid shocking during the vulnerable T-wave; defibrillation deliberately omits synchronization because the rhythm is disorganized.
"You can use an AED for elective cardioversion in a clinic."	An AED is designed for defibrillation only and cannot perform synchronized cardioversion; manual defibrillators with a sync mode are required for elective cardioversion.
"Cardioversion treats ventricular fibrillation just like defibrillation."	Cardioversion is ineffective for ventricular fibrillation because the rhythm is too chaotic to synchronize; defibrillation is the only electrical treatment for VF.
"Defibrillation pads and cardioversion pads are placed differently."	Both procedures use the same pad positions (anterolateral or anteroposterior), but the defibrillator mode—sync on versus sync off—changes the shock delivery, not the pad location.
"A successful shock always restores a normal heart rhythm permanently."	Both cardioversion and defibrillation can restore sinus rhythm acutely, but recurrence is common; antiarrhythmic drugs or ablation are often needed to maintain rhythm.
"Cardioversion is painless and requires no recovery time."	Cardioversion involves sedation, so patients need monitoring for airway and hemodynamics; recovery includes observing for arrhythmia recurrence and sedation side effects.
"Defibrillation can be safely performed on a conscious, breathing patient."	Defibrillation is indicated only for pulseless rhythms; shocking a conscious patient with a perfusing rhythm can trigger ventricular fibrillation or cardiac arrest.
"The shock in cardioversion is delivered immediately upon pressing the button."	In cardioversion, the operator presses a charge button, then a separate discharge button; the defibrillator waits for the next sensed QRS complex to deliver the synchronized shock.
"Atrial fibrillation always requires cardioversion as first-line treatment."	Rate control with medications is often preferred for asymptomatic or older patients; cardioversion is reserved for symptomatic, hemodynamically unstable, or selected persistent cases.
"Defibrillation is a treatment for asystole or pulseless electrical activity."	Defibrillation has no benefit in asystole or PEA; these rhythms require CPR, epinephrine, and reversible cause correction, not an electrical shock.
"Cardioversion requires a lower energy setting than defibrillation always."	Cardioversion for ventricular tachycardia may use 100–200 J, overlapping with defibrillation energy; the key difference is synchronization, not just the joule value.
"You can perform cardioversion without checking for blood clots."	For atrial fibrillation lasting over 48 hours, cardioversion carries a stroke risk from dislodged clots; transesophageal echocardiography or anticoagulation is mandatory beforehand.
"Defibrillation is only performed by doctors in a hospital setting."	Bystanders using an AED perform defibrillation in public settings; early AED use doubles survival from out-of-hospital cardiac arrest compared to CPR alone.
"The terms 'monophasic' and 'biphasic' refer to the pad type."	Monophasic delivers current in one direction, while biphasic delivers current in two directions; biphasic defibrillators achieve success at lower energy and cause less skin burns.
"Cardioversion is only for atrial arrhythmias, never ventricular ones."	Synchronized cardioversion is also used for stable monomorphic ventricular tachycardia; it is avoided in polymorphic VT, which is treated as defibrillation.
"A defibrillator shock can restart a heart that is in asystole."	Asystole indicates no electrical activity; shocks do not restart a flatline heart and may worsen outcomes; high-quality CPR and epinephrine are the standard treatment.
"Cardioversion and defibrillation both use the same electrode pads."	While pads are physically similar, cardioversion requires the defibrillator's sync mode enabled; using standard defibrillation pads without sync mode converts the shock to defibrillation.
"The patient must be intubated before either procedure is performed."	Neither procedure requires routine intubation; cardioversion uses conscious sedation with spontaneous breathing, while defibrillation in arrest uses bag-mask ventilation during CPR.
"A successful defibrillation means the patient has a pulse immediately."	Defibrillation terminates the arrhythmia, but the heart may remain in pulseless electrical activity or asystole; immediate CPR and vasopressors are needed until perfusion returns.
"Cardioversion is contraindicated in patients with pacemakers."	Cardioversion is safe with pacemakers if pads are placed at least 8 cm away from the generator; the device should be interrogated after the procedure for threshold changes.
"Defibrillation is a preventive measure for high-risk cardiac patients."	Defibrillation is a rescue therapy for ongoing arrhythmias; prevention uses implantable cardioverter-defibrillators (ICDs), which detect and shock automatically without external action.
"The shock from cardioversion is delivered at a random point in the cardiac cycle."	Cardioversion delivers the shock 10–20 milliseconds after the R wave, avoiding the T-wave vulnerable period; this synchronization prevents induction of ventricular fibrillation.
"Both cardioversion and defibrillation require gel or pads for conduction."	Both require conductive gel or self-adhesive pads to reduce transthoracic impedance; using bare paddles without gel causes skin burns and ineffective energy delivery.
"A patient who is awake and talking can receive defibrillation."	A talking patient has a perfusing rhythm; defibrillation is contraindicated because it would likely induce cardiac arrest; synchronized cardioversion may be considered for unstable tachycardias.
"Cardioversion is always performed in an operating room or catheterization lab."	Elective cardioversion is commonly performed in monitored ward beds, emergency departments, or ICU settings with sedation and airway equipment; an OR is not mandatory for stable patients.
"Defibrillation success is measured by the heart rhythm on the monitor."	Success is defined by return of spontaneous circulation (ROSC), not just rhythm change; a rhythm may convert to sinus but still require vasopressors and CPR for hemodynamic stability.

Conclusion

Difference Between Cardioversion and Defibrillation lies in timing and energy. Cardioversion is synchronized, using lower shocks for arrhythmias like atrial fibrillation. Defibrillation is unsynchronized, delivering high-energy shocks for cardiac arrest. Choose cardioversion for stable, organized rhythms; choose defibrillation for pulseless, chaotic rhythms like ventricular fibrillation.

FAQs on Difference Between Cardioversion and Defibrillation

What is the main difference between cardioversion and defibrillation?: The main difference is timing and energy: cardioversion delivers a synchronized shock timed to the QRS complex, while defibrillation delivers an unsynchronized high-energy shock to stop chaotic rhythms like ventricular fibrillation.
Which procedure is better for atrial fibrillation, cardioversion or defibrillation?: Cardioversion is better for atrial fibrillation because it uses a lower-energy synchronized shock to restore normal rhythm, whereas defibrillation is designed for life-threatening ventricular arrhythmias and is not used for AFib.
How much does cardioversion cost compared to defibrillation?: Cardioversion typically costs between $2,000 and $10,000 depending on setting and sedation, while defibrillation is usually performed during emergency cardiac arrest care, costing $1,500 to $5,000 as part of a larger resuscitation episode.
Is cardioversion safer than defibrillation for conscious patients?: Yes, cardioversion is safer for conscious patients because it uses synchronized, lower-energy shocks with sedation, whereas defibrillation is an emergency measure for unconscious patients in cardiac arrest with no pulse.
Can a defibrillator be used for cardioversion in an emergency?: Yes, a defibrillator can be used for cardioversion by switching to synchronized mode, but only trained providers should do this because unsynchronized shocks can trigger ventricular fibrillation in stable rhythms.
What is the most common mistake beginners make when choosing between cardioversion and defibrillation?: The most common mistake is using defibrillation for stable tachycardias like atrial flutter, which requires synchronized cardioversion instead; unsynchronized shocks can worsen the rhythm and cause cardiac arrest.
Are cardioversion and defibrillation interchangeable for treating ventricular tachycardia?: No, they are not interchangeable for ventricular tachycardia: stable VT with a pulse requires synchronized cardioversion, while pulseless VT or VF requires immediate unsynchronized defibrillation to restore a perfusing rhythm.
Can I switch from scheduled cardioversion to emergency defibrillation if my condition worsens?: Yes, you can switch from scheduled cardioversion to emergency defibrillation if your rhythm deteriorates into pulseless ventricular tachycardia or fibrillation, because the clinical priority shifts from rhythm restoration to immediate life support.
What real-world scenario uses cardioversion instead of defibrillation?: A real-world scenario for cardioversion is a patient with symptomatic atrial fibrillation and a heart rate of 150 who is stable, where a synchronized shock restores sinus rhythm; defibrillation is reserved for collapse with no pulse.
Which procedure has a higher success rate, cardioversion or defibrillation?: Defibrillation has a higher immediate success rate for terminating ventricular fibrillation (up to 90% with early shocks), while cardioversion success for atrial fibrillation ranges from 50% to 90% depending on duration and underlying heart disease.